SCHEMBL25460141

SCHEMBL25460141

c1ccc2cc3c(cc2c1)oc1cc(-c2cccc4c(-c5nc(-c6ccc7oc8ccccc8c7c6)nc(-c6cccc7ccccc67)n5)cccc24)ccc13

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.38
CHEK2 O96017 1/20 0.36
MAPT P10636 6/20 0.36
ALDH1A1 P00352 6/20 0.36
HPGD P15428 5/20 0.36
HSD17B10 Q99714 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
KDM4E B2RXH2 5/20 0.36
AHR P35869 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
DUSP3 P51452 1/20 0.36
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
ATM Q13315 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
PRKDC P78527 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22161140 0.92 ALDH1A1 (0.41) MAPTALDH1A1HPGDHSD17B10MEN1
SCHEMBL22077546 0.91 ALDH1A1 (0.44) MAPTALDH1A1HPGDHSD17B10MEN1
SCHEMBL22138514 0.90 ALDH1A1 (0.43) MAPTALDH1A1HPGDHSD17B10MEN1
SCHEMBL23821289 0.90 ALOX5 (0.38) ALOX5CHEK2MAPTALDH1A1HPGD
SCHEMBL23845650 0.90 ALDH1A1 (0.38) MAPTALDH1A1HPGDHSD17B10MEN1
SCHEMBL25687045 0.90 ALOX5 (0.36) ALOX5MAPTALDH1A1HPGDHSD17B10
SCHEMBL23283925 0.89 ALDH1A1 (0.37) CHEK2MAPTALDH1A1HPGDHSD17B10
SCHEMBL22240791 0.89 ALDH1A1 (0.46) ALOX5CHEK2MAPTALDH1A1HPGD
SCHEMBL24215921 0.89 ALDH1A1 (0.46) ALOX5CHEK2MAPTALDH1A1HPGD
SCHEMBL22161063 0.89 ALDH1A1 (0.40) ALOX5CHEK2MAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230157168-A1 PLURALITY OF HOST MATERIALS, ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-05-18 US disclosed
US-20230157168-A1 PLURALITY OF HOST MATERIALS, ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-05-18 US disclosed
US-20230141672-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-05-11 US disclosed
US-20230141435-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-05-11 US disclosed
US-20230141672-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-05-11 US disclosed
US-20230141435-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230141672-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME NECTIN4, SOD1, ELAVL1 ALOX5 1506/4885CHEK2 2551/4885MAPT 2415/4885
US-20230157168-A1 PLURALITY OF HOST MATERIALS, ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, EPCAM, NECTIN4 ALOX5 1432/4885CHEK2 2637/4885MAPT 2279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.